| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 27.701 | 28.826 | 29.278 | 7.244 | 4.390 | 468 | 0 | 0 | - |
| Total Income - EUR | - | 27.701 | 28.826 | 29.278 | 7.244 | 4.390 | 468 | 0 | 0 | - |
| Total Expenses - EUR | - | 24.123 | 27.730 | 32.681 | 10.440 | 5.105 | 1.653 | 0 | 0 | - |
| Gross Profit/Loss - EUR | - | 3.578 | 1.097 | -3.404 | -3.196 | -715 | -1.186 | 0 | 0 | - |
| Net Profit/Loss - EUR | - | 2.778 | 810 | -3.696 | -3.310 | -816 | -1.200 | 0 | 0 | - |
| Employees | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Crescendo-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | - | 3.133 | 3.816 | 2.441 | 2.310 | 2.654 | 0 | 0 | 0 | - |
| Inventories | - | 125 | 799 | 1.243 | 1.156 | 1.134 | 0 | 0 | 0 | - |
| Receivables | - | 310 | 0 | -18 | 0 | 29 | 0 | 0 | 0 | - |
| Cash | - | 2.698 | 3.017 | 1.217 | 1.154 | 1.491 | 0 | 0 | 0 | - |
| Shareholders Funds | - | 2.822 | 3.585 | -177 | -3.483 | -4.233 | -5.339 | 0 | -5.339 | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 0 | 40 | - |
| Debts | - | 310 | 232 | 2.618 | 5.793 | 6.887 | 5.339 | 0 | 5.339 | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Crescendo-Med Srl